Nektar Therapeutics【0UNL】銘柄情報

Nektar Therapeutics (0UNL) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

( - )

買値

0.00

売値

0.00

出来高

529

平均取引量 (3 か月)

US$ 1,160,850

財務取引量

0.00 日の範囲 0.00

707.70 52 週間の範囲 707.70

時価総額

企業価値

1.942B

前日終値

0.00

始値

時刻

69.4115

(O)

最終取引時間

VWAP

歳入

55.63M

純利益

-158.1M

発行済株式数

33,786,032

浮動株比率 (%)

86.25%

機関投資家保有比率 (%)

79.83%

配当利回り

PER

-9.26

株価売上高倍率 (PSR)

45.49

1 株当たり利益 (EPS)

-8.09

ベータ

1.14

Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. It develops rezpegaldesleukin, which is in Phase 2b to treat underlying immune system imbalance in people with autoimmune disorder... Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. It develops rezpegaldesleukin, which is in Phase 2b to treat underlying immune system imbalance in people with autoimmune disorders and inflammatory diseases; NKTR-0165 to treat ulcerative colitis, vitiligo, and multiple sclerosis; NKTR-0166 to treat autoimmune disease; NKTR-422 to treat fibrotic diseases; and NKTR-255 to treat solid tumors and large b-cell lymphoma. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; and Merck KGaA. The company was incorporated in 1990 and is headquartered in San Francisco, California. 詳細を表示

セクター

業界

ウェブサイト

www.nektar.com

本社

San Francisco, United States

設立

1990

Nektar Therapeutics is listed in the sector of the ロンドン証券取引所 with ticker 0UNL. The last closing price for Nektar Therapeutics was US$0. Over the last year, Nektar Therapeutics shares have traded in a share price range of US$ 707.70 to US$ 707.70.

Nektar Therapeutics currently has 33,786,032 shares in issue. Nektar Therapeutics has a price to earnings ratio (PE ratio) of -9.26.

期間 †	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	DE
4	0	0	0	0	0	DE
12	0	0	0	0	0	DE
26	707.7	707.7	707.7	4254	707.7	DE
52	707.7	707.7	707.7	3674	707.7	DE
156	47.18	707.7	47.18	8355	124.24395489	DE
260	47.18	707.7	47.18	5621	113.31972897	DE